Stenabolic
Also known as: SR9009, SR-9009
Classification
Unknown
Regulatory Status
Overview
Stenabolic (SR9009) is a synthetic REV-ERB agonist studied in mice for circadian and metabolic effects (energy expenditure, fat mass). Human pharmacokinetics, efficacy, and safety are not established.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
ClassB source cannot establish canonical regulatory or safety fields. The statements below are retained as uncertainty, not as a label-backed verdict. | Regulatory status: not-established | Contraindication: No approved product; not for human use | Warning: Human adverse-effect profile is not established from clinical trials | Adverse effect: not established in controlled human studies | Serious adverse effect: unknown; risk profile not established — unapproved status and lack of human data are the primary practical harms
Pathways
Interactions & cautions
Drug interactions
other metabolic modulators, SARMs, or unapproved performance agents — Unstudied combined risk. (review)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.